
Merck cites EnWave’s REV™ Technology as a Faster, Viable Drying Alternative to Vial-Based Lyophilization for Vaccines and Biologics
EnWave Corporation announces today that Merck & Co. Inc published a research paper citing EnWave’s freezeREV® process as a viable manufacturing…
Read more